MMRGlobal, Inc. (fka MMRF)

[Tulaz1]

MMRGlobal Expands Licensing Initiative in Advance of Stage 2 Meaningful Use Patient Engagement Requirements
LOS ANGELES, CA -- (MARKETWIRE) -- 04/01/13 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHRs"), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced that based on interest in licensing its growing patent portfolio in advance of patient engagement requirements under Stage 2 Meaningful Use to be implemented by January 1, 2014, the Company is expanding its licensing efforts to include additional healthcare professionals, hospitals, ambulatory surgical centers, laboratory systems, pharmacies, mass merchandisers and other vendors and providers while continuing to sell its HIT products and services direct in response to increased interest in the marketplace. Since the founding of MyMedicalRecords in 2005, the Company's patented products and services have grown in value and were the subject of a special report published on January 22, 2013 which concluded that the value of the Company's U.S. HIT patent portfolio could reach between $600 million to $1.1 billion in revenue (http://michaelbass.com/PDF/Patent_Valuation.pdf). Additionally, in January 2009, following the Company's merger with Favrille Inc., MMR acquired a biotech portfolio created at a cost of more than $100 million from which the Company has already signed non-exclusive license agreements for more than $13 million. Management believes that the Company's valuation should include the value of all its intellectual property, similar to other IP-holding companies that have invented and license and sell their IP.
Last week, the Company announced the launch of seamless connectivity between the MyMedicalRecords Personal Health Record and Electronic Medical Record ("EMR") systems in medical clinics starting April 15, 2013. The new features are designed to facilitate two-way connectivity between a MyMedicalRecords PHR and any EMR or laboratory reporting system. Using an HL7 interface, MMR is able to populate data, such as a Continuity of Care Document ("CCD"), directly to the patient as well as lab test results, medication lists and other discrete data directly into a MyMedicalRecords PHR. The system will also be able to push PDFs and other personally managed health information from the patient's confidentially maintained files directly into an EMR or EHR at the total discretion of the patient.
The MMR patent portfolio includes seven U.S. patents: Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240, as well as additional patents internationally including Australia, Canada, New Zealand, Mexico, Japan and Singapore. The Company also has pending applications in Hong Kong, South Korea, Israel, and European nations. The MMR patent portfolio involves inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems.

http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-newsArticle&ID=1801881&highlight=